ACTO Named Top 50 Pharmaceutical Technology Provider

ACTO, a company focused on AI-powered field excellence in the life sciences sector, has been named among the top 50 pharmaceutical technology providers for 2026 by Everest Group. This recognition highlights ACTO's leadership in integrating human intelligence with empathetic AI, particularly in the development of agentic AI designed for the life sciences industry.

According to Durga Ambati, Vice President at Everest Group, the inclusion of ACTO in the Top 50™ Pharmaceutical Technology Providers for 2026 underscores the company's strategic focus and innovative approach.

ACTO's platform is designed to integrate with major commercial technology ecosystems, such as Veeva and Salesforce, further solidifying its position in the broader commercial technology landscape. The company's focus on AI-supported personalization and omnichannel enablement aligns with the growing demand for advanced technologies in the pharmaceutical industry. ACTO's AI SuperAgents are specifically designed to elevate training and coaching, while automating up to 30% of the work embedded in customer-facing roles.

Parth Khanna, Co-founder and CEO of ACTO, expressed gratitude for the recognition. "We have built our expertise into an AI-native platform that is both innovative and compliant with the highest regulatory standards. This recognition validates our strategy and reinforces our commitment to continuous innovation."

Everest Group's Top 50™ research evaluates providers based on a weighted composite score across four key parameters: market adoption and scale, innovation, value realization and outcomes, and client and geographic coverage. ACTO's inclusion in this prestigious ranking is a testament to the company's commitment to excellence and its ability to meet the unique needs of the pharmaceutical industry.

The recognition comes at a time when pharmaceutical companies are increasingly investing in technologies that can improve commercial and medical execution. ACTO's AI-powered Field Excellence Platform and role-based SuperAgents are well-positioned to support these efforts, providing a robust solution for enhancing field readiness, operational efficiency, and customer engagement.

ACTO's focus on AI and its application in the life sciences sector positions it as a leader in the evolving landscape of pharmaceutical technology. As the industry continues to embrace AI-driven solutions, ACTO is well-equipped to support pharmaceutical companies in their journey towards more efficient and effective field operations.